Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 47

1.

The effect of low-molecular-weight heparin on cancer survival. A systematic review and meta-analysis of randomized trials.

Lazo-Langner A, Goss GD, Spaans JN, Rodger MA.

J Thromb Haemost. 2007 Apr;5(4):729-37. Review.

2.
3.

Meta-analysis of venous thromboembolism prophylaxis in medically Ill patients.

Kanaan AO, Silva MA, Donovan JL, Roy T, Al-Homsi AS.

Clin Ther. 2007 Nov;29(11):2395-405. Review.

PMID:
18158080
4.

The effect of low molecular weight heparin on survival in cancer patients: an updated systematic review and meta-analysis of randomized trials.

Sanford D, Naidu A, Alizadeh N, Lazo-Langner A.

J Thromb Haemost. 2014 Jul;12(7):1076-85. doi: 10.1111/jth.12595. Epub 2014 Jun 19. Review.

5.

Low-molecular-weight heparins are superior to vitamin K antagonists for the long term treatment of venous thromboembolism in patients with cancer: a cochrane systematic review.

Akl EA, Barba M, Rohilla S, Terrenato I, Sperati F, Muti P, Schünemann HJ.

J Exp Clin Cancer Res. 2008 Jul 18;27:21. doi: 10.1186/1756-9966-27-21. Review.

6.

Intravenous low-molecular-weight heparins compared with unfractionated heparin in percutaneous coronary intervention: quantitative review of randomized trials.

Dumaine R, Borentain M, Bertel O, Bode C, Gallo R, White HD, Collet JP, Steinhubl SR, Montalescot G.

Arch Intern Med. 2007 Dec 10;167(22):2423-30. Review.

PMID:
18071163
7.

Low-molecular-weight heparin vs unfractionated heparin for perioperative thromboprophylaxis in patients with cancer: a systematic review and meta-analysis.

Akl EA, Terrenato I, Barba M, Sperati F, Sempos EV, Muti P, Cook DJ, Schünemann HJ.

Arch Intern Med. 2008 Jun 23;168(12):1261-9. doi: 10.1001/archinte.168.12.1261. Review.

PMID:
18574082
8.

The effect of anticoagulants on cancer risk and survival: systematic review.

Tagalakis V, Blostein M, Robinson-Cohen C, Kahn SR.

Cancer Treat Rev. 2007 Jun;33(4):358-68. Epub 2007 Apr 3. Review.

PMID:
17408861
9.

Clinical studies with anticoagulants to improve survival in cancer patients.

Gerotziafas GT, Papageorgiou C, Hatmi M, Samama MM, Elalamy I.

Pathophysiol Haemost Thromb. 2008;36(3-4):204-11. doi: 10.1159/000175158. Epub 2009 Jan 27. Review.

PMID:
19176993
10.

Anticoagulation for the initial treatment of venous thromboembolism in patients with cancer: a systematic review.

Akl EA, Rohilla S, Barba M, Sperati F, Terrenato I, Muti P, Bdair F, Schünemann HJ.

Cancer. 2008 Oct 1;113(7):1685-94. doi: 10.1002/cncr.23814. Review.

11.

Thromboprophylaxis for patients with cancer and central venous catheters: a systematic review and a meta-analysis.

Akl EA, Kamath G, Yosuico V, Kim SY, Barba M, Sperati F, Cook DJ, Schünemann HJ.

Cancer. 2008 Jun;112(11):2483-92. doi: 10.1002/cncr.23479. Review.

12.

Thromboprophylaxis in cancer patients with central venous catheters. A systematic review and meta-analysis.

Chaukiyal P, Nautiyal A, Radhakrishnan S, Singh S, Navaneethan SD.

Thromb Haemost. 2008 Jan;99(1):38-43. doi: 10.1160/TH07-07-0446. Review.

PMID:
18217132
13.

Rituximab maintenance for the treatment of patients with follicular lymphoma: systematic review and meta-analysis of randomized trials.

Vidal L, Gafter-Gvili A, Leibovici L, Dreyling M, Ghielmini M, Hsu Schmitz SF, Cohen A, Shpilberg O.

J Natl Cancer Inst. 2009 Feb 18;101(4):248-55. doi: 10.1093/jnci/djn478. Epub 2009 Feb 10. Review.

PMID:
19211444
14.

Adjunct low-molecular-weight heparin to improve live birth rate after recurrent implantation failure: a systematic review and meta-analysis.

Potdar N, Gelbaya TA, Konje JC, Nardo LG.

Hum Reprod Update. 2013 Nov-Dec;19(6):674-84. doi: 10.1093/humupd/dmt032. Epub 2013 Aug 2. Review.

PMID:
23912476
15.

Intravenous magnesium sulphate and sotalol for prevention of atrial fibrillation after coronary artery bypass surgery: a systematic review and economic evaluation.

Shepherd J, Jones J, Frampton GK, Tanajewski L, Turner D, Price A.

Health Technol Assess. 2008 Jun;12(28):iii-iv, ix-95. Review.

16.

Venous thromboembolism prevention in gynecologic cancer surgery: a systematic review.

Einstein MH, Pritts EA, Hartenbach EM.

Gynecol Oncol. 2007 Jun;105(3):813-9. Epub 2007 Apr 20. Review.

PMID:
17449089
17.

Safety and efficacy of low molecular weight heparins in children: a systematic review of the literature and meta-analysis of single-arm studies.

Bidlingmaier C, Kenet G, Kurnik K, Mathew P, Manner D, Mitchell L, Krümpel A, Nowak-Göttl U.

Semin Thromb Hemost. 2011 Oct;37(7):814-25. doi: 10.1055/s-0031-1297173. Epub 2011 Dec 20. Review.

PMID:
22187405
18.

Improved cancer mortality with low-molecular-weight heparin treatment: a review of the evidence.

Cosgrove RH, Zacharski LR, Racine E, Andersen JC.

Semin Thromb Hemost. 2002 Feb;28(1):79-87. Review.

PMID:
11885028
19.

Anticoagulant prophylaxis to prevent asymptomatic deep vein thrombosis in hospitalized medical patients: a systematic review and meta-analysis.

Lloyd NS, Douketis JD, Moinuddin I, Lim W, Crowther MA.

J Thromb Haemost. 2008 Mar;6(3):405-14. Epub 2007 Nov 20. Review.

20.

Low-molecular-weight heparin and cancer.

Zacharski LR, Ornstein DL, Mamourian AC.

Semin Thromb Hemost. 2000;26 Suppl 1:69-77. Review.

PMID:
11011810

Supplemental Content

Support Center